Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


06.05.2019

1 BMC Gastroenterol
2 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Haemophilia
1 J Hepatol
1 Lancet Gastroenterol Hepatol
1 Lancet Infect Dis
3 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Gastroenterol

  1. HSU WF, Lai HC, Su WP, Lin CH, et al
    Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
    BMC Gastroenterol. 2019;19:63.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  2. ZOU WY, Choi K, Kramer JR, Yu X, et al
    Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05641.
    PubMed     Text format     Abstract available

  3. VOILS CI, King HA, Thorpe CT, Blalock DV, et al
    Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05621.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  4. CHALOUNI M, Sogni P, Miailhes P, Lacombe K, et al
    Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
    Eur J Gastroenterol Hepatol. 2019 Apr 25. doi: 10.1097/MEG.0000000000001408.
    PubMed     Text format     Abstract available


    Gastroenterology

  5. LOHMANN V, Bartenschlager R
    Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36726.
    PubMed     Text format    


    Haemophilia

  6. THALAPPILLIL A, Ragni MV, Comer DM, Yabes JG, et al
    Incidence and risk factors for hepatocellular cancer in individuals with haemophilia: A National Inpatient Sample Study.
    Haemophilia. 2019;25:221-228.
    PubMed     Text format     Abstract available


    J Hepatol

  7. HONG J, Kushner T, Dieterich D, Garry D, et al
    Reducing mother-to-child transmission of HCV: Is it attainable with a multidisciplinary approach?
    J Hepatol. 2019 Apr 24. pii: S0168-8278(19)30079.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  8. FLANAGAN S, Kunkel J, Appleby V, Eldridge SE, et al
    Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2018 Nov 23. pii: S2468-1253(18)30318.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  9. CHEN DS
    Taiwan commits to eliminating hepatitis C in 2025.
    Lancet Infect Dis. 2019;19:466-467.
    PubMed     Text format    


    PLoS One


  10. Retraction: Role of Hepatitis C Virus Induced Osteopontin in Epithelial to Mesenchymal Transition, Migration and Invasion of Hepatocytes.
    PLoS One. 2019;14:e0216026.
    PubMed     Text format    


  11. Retraction: Activation of TGF-beta1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-beta1 in Hepatic Stellate Cell Activation and Invasion.
    PLoS One. 2019;14:e0216025.
    PubMed     Text format    

  12. CHIKOVANI I, Ompad DC, Uchaneishvili M, Sulaberidze L, et al
    On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study.
    PLoS One. 2019;14:e0216123.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  13. PRENTOE J, Velazquez-Moctezuma R, Augestad EH, Galli A, et al
    Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
    Proc Natl Acad Sci U S A. 2019 Apr 30. pii: 1822002116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: